Trial
NCT00416884
Flu,Alemtuzumab,and TBI Followed By Donor Stem Cell Chronic Phase CML
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Leukemia
Intervention
Campath
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-09-27